Clinical Trials Insight: 700028283
Phase of Trial: Phase I
Latest Information Update: 21 Mar 2011
At a glance
- Drugs AR 9281 (Primary)
- Indications Hypertension; Metabolic syndrome; Type 2 diabetes mellitus
- Focus Adverse reactions; Biomarker; Pharmacokinetics
- Sponsors Arete Therapeutics
- 23 Dec 2008 Status changed from planning to completed, as reported in an Arete Therapeutics media release.
- 18 Dec 2008 Results announced in an Arete Therapeutics media release.
- 08 Nov 2007 New trial record.